Congenital Muscular Dystrophy With Dropped Head Linked to the LMNA Gene in a Brazilian Cohort

Carregando...
Imagem de Miniatura
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
PEDIATRIC NEUROLOGY, v.50, n.4, p.400-406, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: Congenital muscular dystrophy is a clinically and genetically heterogeneous group of myopathies. Congenital muscular dystrophy related to lamin A/C is rare and characterized by early-onset hypotonia with axial muscle weakness typically presenting with a loss in motor acquisitions within the first year of life and a dropped-head phenotype. METHODS: Here we report the clinical and histological characteristics of four unrelated Brazilian patients with dropped-head syndrome and mutations in the LMNA gene. RESULTS: All patients had previously described mutations (p.E358K, p.R249W, and p.N39S) and showed pronounced cervical muscle weakness, elevation of serum creatine kinase, dystrophic pattern on muscle biopsy, and respiratory insufficiency requiring ventilatory support. Three of the patients manifested cardiac arrhythmias, and one demonstrated a neuropathic pattern on nerve conduction study. CONCLUSION: Although lamin A/C related congenital muscular dystrophy is a clinically distinct and recognizable phenotype, genotype/phenotype correlation, ability to anticipate onset of respiratory and cardiac involvement, and need for nutritional support remain difficult.
Palavras-chave
congenital muscular dystrophy, dropped-head syndrome, LMNA gene, laminopathy, muscle biopsy, genetics
Referências
  1. Benedetti S, 2005, J NEUROL NEUROSUR PS, V76, P1019, DOI 10.1136/jnnp.2004.046110
  2. Bönnemann C G, 2011, Neuromuscul Disord, V21, P513, DOI 10.1016/j.nmd.2011.04.004
  3. Chemla JC, 2010, MUSCLE NERVE, V42, P839, DOI 10.1002/mus.21820
  4. Hattori A, 2012, NEUROMUSCULAR DISORD, V22, P149, DOI 10.1016/j.nmd.2011.08.009
  5. Komaki H, 2011, NEUROMUSCULAR DISORD, V21, P563, DOI 10.1016/j.nmd.2011.04.010
  6. Menezes MP, 2012, NEUROLOGY, V78, P1258, DOI 10.1212/WNL.0b013e318250d839
  7. Muchir A, 2004, PHYSIOLOGY, V19, P309, DOI 10.1152/physiol.00022.2004
  8. Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009
  9. Prigogine C, 2010, PEDIATR NEUROL, V43, P283, DOI 10.1016/j.pediatrneurol.2010.05.016
  10. Quijano-Roy S, 2012, NEUROMUSCULAR DISORD, V22, pS68, DOI 10.1016/j.nmd.2012.08.003
  11. Quijano-Roy S, 2008, ANN NEUROL, V64, P177, DOI 10.1002/ana.21417
  12. Reed UC, 2009, ARQ NEURO-PSIQUIAT, V67, P144, DOI 10.1590/S0004-282X2009000100038
  13. Scharner J, 2011, HUM MUTAT, V32, P152, DOI 10.1002/humu.21361
  14. Sewry CA, 2010, ACTA NEUROPATHOL, V120, P343, DOI 10.1007/s00401-010-0727-5
  15. van Berlo JH, 2005, J MOL MED-JMM, V83, P79, DOI 10.1007/s00109-004-0589-1
  16. Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028